reposted and reported in youarewithinthenorms.com
NORMAN J CLEMENT RPH., DDS, NORMAN L. CLEMENT PHARM-TECH, MALACHI F. MACKANDAL PHARMD, BELINDA BROWN-PARKER, IN THE SPIRIT OF JOSEPH SOLVO ESQ., INC.T. SPIRIT OF REV. IN THE SPIRIT OF WALTER R. CLEMENT BS., MS, MBA. HARVEY JENKINS MD, PH.D., IN THE SPIRIT OF C.T. VIVIAN, JELANI ZIMBABWE CLEMENT, BS., MBA., IN THE SPIRIT OF THE HON. PATRICE LUMUMBA, IN THE SPIRIT OF ERLIN CLEMENT SR., EVELYN J. CLEMENT, WALTER F. WRENN III., MD., JULIE KILLINGSWORTH, RENEE BLARE, RPH, DR. TERENCE SASAKI, MD LESLY POMPY MD., CHRISTOPHER RUSSO, MD., NANCY SEEFELDT, WILLIE GUINYARD BS., JOSEPH WEBSTER MD., MBA, BEVERLY C. PRINCE MD., FACS., NEIL ARNAND, MD., RICHARD KAUL, MD., LEROY BAYLOR, JAY K. JOSHI MD., MBA, ADRIENNE EDMUNDSON, ESTER HYATT PH.D., WALTER L. SMITH BS., IN THE SPIRIT OF BRAHM FISHER ESQ., MICHELE ALEXANDER MD., CUDJOE WILDING BS, MARTIN NJOKU, BS., RPH., IN THE SPIRIT OF DEBRA LYNN SHEPHERD, BERES E. MUSCHETT, STRATEGIC ADVISORS
INTRODUCTION
Comes now Norman J Clement, a Pharmacist and Dentist, owner of Pronto Pharmacy LLC, of Tampa, Florida, and hereby states;
PHARMACY COMPOUNDING WHILE BLACK!!!
The DEA’s August 29, 2019, raid on Pronto Pharmacy LLC. and its owner, Norman J Clement, was an act of Tulsafication, brazen deliberate misconduct against a licensed retail pharmacy that is licensed by law to compound medications. It will not go unpunished as it intends to file a $40 Billion dollar lawsuit against DEA, Ohio State University, et al.
TULSAFICATION: A EUGENIC CONCEPT OF COGNITIVE DISTORTION OF NON-ACCEPTANCE WITHIN THE CULTURE OF RACISM, “BLACKS ARE NOT SUPPOSED TO BE PHARMACISTS.”
…WALTER R. CLEMENT
These cases are about bad science, law, and poor training. Diversion Investigator Richard Albert prepared a warrant, an “opinion based on a red flag” that Pronto Pharmacy engaged in manufacturing controlled substances. This is an assumption that a crime was committed within the Pronto Pharmacy, wherein a licensed pharmaceutical company, by law, can compound medication. The Diversion Investigator wrote,
ILLEGAL MANUFACTURING :
Between January 2018 and May 2019, the Respondent was engaged in manufacturing controlled substances, as that term is defined in the CSA, without a separate DEA registration authorizing it to manufacture controlled substances, in violation of 21 U.S.C. § 841(a)(1) and 21 C.F.R. § 1301.13(e). ALJ Ex. 1, ¶ 20-28.
“In addition, the Government previewed that its evidence will show that the Respondent unlawfully manufactured controlled substances, specifically oxycodone and hydromorphone, without a manufacturer’s registration.”
To support this allegation, the Government intended to show that in May 2012, the Respondent’s owner, Mr. Norman J. Clement, Sr., told DEA investigators that he compounded oxycodone and hydromorphone because it was cheaper than obtaining them from distributors.
THE MANUFACTURING OF OXYCODONE
Pronto Pharmacy does not manufacture Oxycodone or Hydromorphone, which is a far more complex process. Pronto would have to:
- Acquire large tons of harvested opium paste from Tasmania, India, or Afghanistan, transporting these volumes to Tampa, Fl., for processing.
- To process the opium paste, large volumes of agents, reagents, equipment, and space would be needed, notwithstanding the fact that to bring the product Oxycodone and Hydromorphone to a pharmaceutical grade that meets FDA purity standards.
- The water and electrical bills at Pronto Pharmacy would be enormous.
The manufacturing of Oxycodone into a bulk product is an extremely complex procedure and would involve:
(see Google Scholar manufacture Oxycodone)
Oxycodone is manufactured in high yields and with high purity using codeine or salt of codeine as the starting material. The manufacturing process involves the following steps:
- (a) codeine or a codeine salt (e.g., codeine phosphate) is converted into the intermediate N-carboalkoxy- or N-carboaryloxynorcodeine,
- (b) the intermediate N-carboalkoxy- or N-carboaryloxynorcodeine resulting from step (a) is oxidized to yield the intermediate N-carboalkoxy- or N-carboaryloxynorcodeinone;
- (c) the intermediate N-carboalkoxy- or N-carboaryloxynorcodeinone resulting from step (b) is enolized with a base and the resultant enolate is thereafter methylated to yield the intermediate N-carboalkoxy- or N-carboaryloxynorthebaine;
- (d) the intermediate N-carboalkoxy- or N-carboaryloxynorthebaine resulting from step (c) is reduce to yield thebaine;
- (e) the thebaine resulting from step (d) is oxidized to yield the intermediate 14-hydroxycodeinone; and
- (f) the intermediate 14-hydroxycodeinone resulting from step (e) is hydrogenated to yield oxycodone.
THERE WAS NOT ONE SINGLE CAPSULE EVER MANUFACTURED AT PRONTO PHARMACY
1. There is not one piece of equipment that the DEA seized from Pronto that was used in manufacturing. All equipment taken was for compounding
2. All compounded medications were purchased from two wholesalers (Fagron and B&B)
3. There is not a single controlled substance compounded for encapsulation at Pronto Pharmacy, which was manufactured at the pharmacy or by a Pronto pharmacist and/or their technicians.
Here are the containers. ( see below)
4. The containers of powders were obtained from B&B Pharmaceutical and were recorded into the CSOS system, which reported back to the DEA and wholesalers. Therefore, Richard James Albert should have known this but chose to falsify his warrant in order to put Pronto out of business and its owners in prison.
THE DEA IS A CRIMINAL ENTERPRISE OF THE UNITED STATES GOVERNMENT DEPART OF JUSTICE TARGETING THOSE ENGAGED IN STRONG-ARM ROBBERY, ESPECIALLY BLACK AND BROWN MEN OF COLOR AT AIRPORTS IN AMERICA
DEA IS MOVING THE GOALPOST BACKWARD AND FORWARD AND SETTING QUOTAS
We see this early in the case of Pronto Pharmacy when Diversion Investigator Richard James Albert (DI Albert) came upon compounding. When he could not repeatedly find anything wrong with the pharmacy’s records, His handlers instructed him to redefine this long-standing pharmaceutical methodology as manufacturing.
It is more than clear that the DEA Diversion Investigators were operating absent the law based on mis-facts, lies, and distortions. DEA has learned well.
When there is no evidence of wrongdoing, DI Richard James Albert’s handlers cleverly instructed him to redefine the meaning of pharmaceutical procedures to accomplish their goals.
The Diversion Investigator’s charges and findings were easily scientifically debunked. It became clear from his court testimony he did not understand compounding or its procedures.
But he likely learned from his handlers like Amy Hickerson, who was guiding him on diverting both meanings to convince a Federal Administrative Judge to secure a warrant to shut Pronto Pharmacy LLC down. Additionally, he testified that he did not “know or understand the law(s) or how any law applies to the practice of Pharmacy. Florida Statute 499.1.2 states the wholesaler must assess the purchases of control medication by an individual pharmacy.
1. SEE BELOW VIDEO MICHAEL JACKSON RPH, CEO OF FLORIDA PHARMACIST ASSOCIATION CE PROGRAM WITH THE FLORIDA A&M UNIVERSITY PHARMACIST ALUMNI JUNE 2017, NEW ORLEANS, LA, ON CRIMINAL BACKGROUND CHECKS
DEA ADMINISTRATIVE COURTS (OF THE KANGAROOS)
DEA, supported by its unique unconstitutional court systems, permits the agency to operate as rogues in the spirit of impunity in violating patients’ rights to privacy and treatment by imposing upon a licensed Pharmacist to conduct criminal background checks.
DEA agents can get away with this because they have the power to remove Control Substance Registration, open an investigation, or frequent your business until they get the pharmacist to do what they want.
This practice is known by the DEA Agents as Skull Fucking, which amounts to abuse, and all DEA supervisors are well aware of and encourage these practices.
2.(SEE BELOW VIDEO MICHAEL JACKSON RPH, CEO FLORIDA PHARMACIST ASSOCIATION CE PROGRAM WITH THE FLORIDA A&M UNIVERSITY PHARMACIST ALUMNI JUNE 2017, NEW ORLEANS, LA)
IMG_2363FL. STATUE 499.1.2 PAR.18
ARGUMENT
The year is 1959, the great trumpeter Miles Davis, stepped outside of the Bird Land Theater in New York City, where he was top billing, to smoke a cigarette. Then, a rookie cop walking the beat approached him and said, “You can’t stand there; move along.” Miles stated, “I’ve done nothing wrong. I’m not going anywhere..my name is on the Marquee…”
In a brazen act of Tulsafication, a tussle ensued. Miles was struck over the head with a billy club by a drunk New York City detective and arrested. The great writer and Chairperson of Institute for Research in African-American Studies (IRAAS), Columbia University, Dr. Farah Griffin, so eloquently put it, “No matter how much you have accomplished or what you have achieved, the system of racism in America will remind you what you are.” iii ( ft note PBS miles)
The great trumpeter Dizzy Gillespie was asked in 1984 to access the incident of Miles Davis, he stated “no matter how big you get racism will appear like a dragon with steam rolling out its nose.
The year is 2020, in the 21st Century, 60 years removed from 1959. As a highly trained Medical Practitioner (Physician, Dentist, Pharmacist), your reputation means everything, especially when individuals are of an international cultural background; they are further held in high esteem by their entire village, family name, and nation of birth.
We are role models, having aspired against great odds and barriers, achieving a degree marking great success and accomplishments. Thus, when the United States Drug Enforcement Agency (DEA), in a brazen act of Tulsafication, targets any healthcare practice, particularly those owned by African Americans and people of color, the public, through media perceptions, is programmed to believe one to be guilty.
AS BLACK PHARMACY OWNERS, WE ARE LOW-HANGING FRUIT
We are but role models and low-hanging fruit who are praised and paraded before our congregations of elementary and high school children and churches but trained to remain silent and to have no opinion, offer no ideas or input and go along just to get along. yet remain both invisible and silent.
Your professional colleagues and organizations become non-engaged, intimated by your presence, and failing to bring light on the sheer incompetence and lawlessness of these DEA Diversion Investigators.
Like any Black Person, we are but invisible men/women and are Black medical practitioners who possess the education, knowledge, achievements, and loyalty to address the needs of people. That makes us dangerous and viewed with disdain by those who aim to restrict our wisdom.
We are but low-hanging fruit for the DEA. Your professional license, for what it is worth, as a physician, dentist, or pharmacist is now that of a common drug street dealer.
CALL REVEREND SHARPTON YOU ARE TARGETTED PLAIN AND SIMPLE
You are but low-hanging fruit. Don’t bring attention to yourself; you know how it is. Invisible, filtered. And like any person, to protect what’s left of their reputation, most would rather fold than fight. Like their black counterparts, it’s better to remain silent and do as you’re told. But to this group, their attitudes are reflective of Frederick Douglas’ speech of 1857:
“Let me give you a word of the philosophy of reform. The whole history of the progress of human liberty shows that all concessions yet made to her august claims have been born of earnest struggle. The conflict has been exciting, agitating, all-absorbing, and for the time being, putting all other tumults to silence. It must do this or it does nothing. If there is no struggle there is no progress. Those who profess to favor freedom and yet deprecate agitation are men who want crops without plowing up the ground; they want rain without thunder and lightning. They want the ocean without the awful roar of its many waters.”
THE TARGETING PACKAGES
Lincourt Pharmacy, Clearwater, Fl.; Pronto Pharmacy LLC; At Cost Pharmacy of Fort Myers, Fl; Gulf Med Pharmacy of Cape Coral, Florida; Oak Hill Pharmacy of Oak Hill, West Virginia; Superior Drugs, Tampa, Florida.
Also, these providers have been targeted: Dr. Neil Anand, MD, DR. TERENCE SASAKI, MD., Dr.Shiva Akula, MD, Dr. Arnold Feldman, MD, Dr. Clarence Verdell, MD, Dr. Paul Volkman, MD, Dr. Harold Eugene Fletcher, PharmD., Dr. Dralves Edward, DO, Drs. Felix Bruzela, Howard Adelglass, Gregory Belcher, Valisinni Ganesh, Beverly Prince, Michele Clark, and Linda Cheeks, to this date, have neither violated nor broken any laws.
All control medications in these Pharmacies have been dispensed according to CSA guidelines, and licensed medical/dental practitioners legally wrote all prescriptions filled by these pharmacies. Most interesting, all the black pharmacist had never encountered anything within the criminal justice law enforcement system until after they got their degrees and opened up their businesses.
dale sisco esq; attorney for Pronto Pharmacy,…2019
“….Norman – I have reviewed the new DOH complaint. One of the individuals present, Amie Hickerson, is the new Diversion Group Supervisor in the Tampa DEA Office. She replaced Roberta Goralczyk. Her participation in this inspection is particularly troubling because the DEA is cracking down on compounding pharmacies. Two important aspects of the distinction between “dispensing” and “manufacturing” are that retail pharmacies are permitted to….”
Yet it is clear that the DEA agents were operating in absence from the law whereby Richard Albert testified on January 28, 2020, in a DEA Federal Court Hearing that he did not “Know or understand the law(s) or how any law apply to the practice of Pharmacy.” There is no evidence that any medication was being diverted.
According to Leo Beletsky and Jeremy Goulka’s September 2018 article, “The Federal Agency That Fuels the Opioid Crisis,” in the New York Times:(1)
“The Drug Enforcement Administration, the agency that most directly oversees access to opioids, deserves much of the blame for these deaths. Because of its incompetence, the opioid crisis has gone from bad to worse. The solution: overhauling the agency, or even getting rid of it entirely.”
DEA Diversion Investigator Richard James Albert so entered the premises of Pronto Pharmacy LLC., based on the assumption that Pharmacist Norman J Clement, his family, and those employed were illegally manufacturing Oxycodone and Hydromorphone based on suspicion and dispensing high doses of illegally controlled prescriptions.
All controlled and non-controlled medications have been properly prescribed by a licensed physician for treatment of a disease state, supported by radiographs, physical examination, and treatment plan, all part of the patient’s medical/dental records.
DI Albert purposely withheld relevant facts by eviscerating the patient-practitioner relationship by using Google Maps to track the distance traveled by these patients to have their prescriptions filled and the patients paying in cash. This is negligence. His handlers have taught him well. Jack Folson, a Pharmacist Expert, writes:
“Currently, the DEA has no statistical guidelines or law to support or establish boundary levels, which are indicative of criminal acts when filling any Control prescription written for patients by a physician who has performed a thorough physical examination, diagnoses supported by medical/dental radiographs and treatment plan. The DEA guidelines are tactic acts that specifically target African American pharmacists.”
THE DEA AND THE MIS-EDUCATION OF THE PUBLIC
The DEA, with cleverness, has redefined Narcotic Analgesic Medications(NAM) into the word Opioids. Neither are accepted for recreational or experimental use. There are dangers associated with Narcotic Analgesic Medication(NAM) for the treatment of pain, as with any medication used therapeutically.
As pharmacists, we learn all medications are dangerous, every last one of them. Importantly, all medications taken for the treatment of any disease conditions in order to sustain life will result in dependency (addiction) and, when taken beyond their therapeutic dose, will cause harm and possibly death.
“As Black practitioner, I early found myself treating disease pathology and the pathology of oppression”…norm rph., DDS.
NAMs are a very important class of medications for the control and treatment of pain. Most importantly, when NAMs are selected for the use of pain, they may and will cause dependency.
Further, unless in the case of an anaphylaxis (allergic) reaction, there are very few recordings of death from this class of medications when NAMs are properly prescribed, monitored, and given at a therapeutic dose level. Perhaps it is death that the DEA has been looking at. Chemotherapy should be their focus when asking how many people die each day when given a therapeutic dose of chemotherapy.
SHOW US THE ALGORITHMS, AND IT WILL SHUT DOWN THE DEA
e37d436b-5a82-4a8d-aade-6e9665625429
FOR NOW, YOU ARE WITHIN
THE NORMS
